Delivery Order SPE2DB20D3101-SPE2DB24FQZD9
Award Date 1/16/24
Potential Completion Date 2/6/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,667.29, is for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of October 4, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,871.50 firm fixed-price contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,538.79 firm fixed-price contract is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has a period of performance ending on December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,903.03, is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,325.14 contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a specialty medication, with a period of performance through February 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, to provide a broad range of pharmaceutical products and medical...
- This is a $21,325.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a prescription medication, with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAGRISSO 80 MG TABLET 30S. The delivery order is a firm fixed-price contract with a ceiling value of $10,538.79 and an ultimate completion date of October 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,616.37 firm-fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The award is valued at $10,508.31 and has a firm fixed price. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader federal contracting activities with various defense...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQZD9Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAGRISSO 80 MG TABLET 30S. The delivery order, valued at $10,538.79, has a firm fixed price and is set to be completed by February 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition.
Generated 5/13/25, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 1/16/24 |